Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences

robot
Abstract generation in progress

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, announced its participation in three upcoming healthcare conferences in late February and early March 2026. President and CEO Jasbir S. Seehra, Ph.D., will present at these events, which include the Oppenheimer 36th Annual Healthcare Life Sciences Conference, TD Cowen 46th Annual Health Care Conference, and Leerink Partners Global Healthcare Conference. The company focuses on developing therapeutics for disorders linked to dysfunctional TGF-ß family protein signaling.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)